journal article·2025-08-27

Drug Repurposing with Topical Paclitaxel Delivery for Psoriasis Treatment Enabled by Plant-Inspired Molecular Assembly

Han Liu, Wei Xia, Yujue Meng, Quangang Xu, Zihan Xia, Bahtiyor Muhitdinov, Ergang Liu, Huan Shen, Yongzhuo Huang

ACS Applied Materials & Interfaces· Volume 17· Issue 34
Publisher page

Abstract

Psoriasis is a chronic inflammatory skin disease, notably characterized by the hyperproliferation of epidermal cells and infiltration of inflammatory cells. Paclitaxel (PTX), beyond its canonical roles in microtubule inhibition and proliferation suppression, has recently garnered increasing attention for its promising therapeutic potential in inflammatory diseases. However, PTX is constrained by its low solubility and poor permeability in topical applications. Based on the applications of Hansen Solubility Parameters in predicting coassembled systems, we herein identified a series of herb-derived small molecules with anti-inflammatory and antioxidant properties that enhance the solubility of PTX. Among them, glycyrrhizic acid not only enhanced the solubility of PTX by nearly 400-fold but also coassembled with PTX to form nanoparticles (PGNs). PGNs featured a high PTX payload (over 30%) and notable skin retention free of excipients and surfactants. PGNs were loaded into a gel, and the resultant PGN@Gel exhibited superior therapeutic efficacy against psoriasis while concomitantly mitigating cutaneous irritation. This coassembly system provides a simple yet efficient approach for solubilizing poorly soluble drugs, thereby broadening the application of PTX-based topical delivery formulations in psoriasis treatment.
Source: openalex_inverted_index · Quality: baseline

Research context

OpenAlex topics: Pharmacological Effects of Natural Compounds · Advancements in Transdermal Drug Delivery · Dermatology and Skin Diseases

SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.

Affiliations

Shanghai Institute of Materia Medica

Chinese Academy of Sciences

University of Chinese Academy of Sciences

Zhongshan Institute for Drug Discovery, Shanghai Institute of Materia Medica

School of Chinese Materia Medica, Nanjing University of Chinese Medicine, 138 Xianlin Avenue, Nanjing 210023, China

School of Pharmacy

China Pharmaceutical University

Institute of Bioorganic Chemistry, Uzbekistan Academy of Sciences, 83 M. Ulughbek Street, Tashkent 100125, Uzbekistan

Funding

Natural Science Foundation of Shanghai Municipality · Guangdong Provincial Department of Science and Technology · Zhongshan Science and Technology Bureau · National Key Research and Development Program of China · Science and Technology Commission of Shanghai Municipality · National Natural Science Foundation of China · Chinese Academy of Sciences · Social welfare and basic research projects of Zhongshan city

References (46)

Show source-provided references
1. 10.1002/JLB.5MR0120-439R10.1002/JLB.5MR0120-439R ↗
2. 10.54517/jbrha331510.54517/jbrha3315 ↗
3. 10.1007/s11926-007-0075-110.1007/s11926-007-0075-1 ↗
4. 10.1146/annurev.immunol.22.012703.10475810.1146/annurev.immunol.22.012703.104758 ↗
5. 10.1007/s13555-021-00521-z10.1007/s13555-021-00521-z ↗
6. 10.1159/00021108110.1159/000211081 ↗
7. 10.1097/00007890-200201270-0001110.1097/00007890-200201270-00011 ↗
8. 10.1016/j.biopha.2017.11.00310.1016/j.biopha.2017.11.003 ↗
9. 10.1016/j.jaad.2003.09.01810.1016/j.jaad.2003.09.018 ↗
10. 10.1208/s12249-019-1413-010.1208/s12249-019-1413-0 ↗
11. 10.1208/s12249-025-03118-310.1208/s12249-025-03118-3 ↗
12. 10.1021/acsami.3c1765910.1021/acsami.3c17659 ↗
13. 10.1021/acsami.2c1989910.1021/acsami.2c19899 ↗
14. 10.1016/j.cis.2020.10234410.1016/j.cis.2020.102344 ↗
15. 10.1016/j.ijpharm.2007.08.05710.1016/j.ijpharm.2007.08.057 ↗
16. 10.2217/nnm-2018-028810.2217/nnm-2018-0288 ↗
17. 10.1021/acs.nanolett.4c0002910.1021/acs.nanolett.4c00029 ↗
18. 10.1016/j.bioactmat.2021.06.03510.1016/j.bioactmat.2021.06.035 ↗
19. 10.1021/acsami.8b2233610.1021/acsami.8b22336 ↗
20. 10.2147/IJN.S44926810.2147/IJN.S449268 ↗
21. 10.1186/s12951-023-02254-x10.1186/s12951-023-02254-x ↗
22. 10.1016/j.cclet.2024.10986910.1016/j.cclet.2024.109869 ↗
23. 10.1016/j.bioadv.2024.21382410.1016/j.bioadv.2024.213824 ↗
24. 10.1002/jcc.2122410.1002/jcc.21224 ↗
25. 10.1002/jcc.2029110.1002/jcc.20291 ↗
26. 10.1063/1.44811810.1063/1.448118 ↗
27. Pharmacopoeia, C. Pharmacopoeia of the People’s Republic of China; China Medical Science Press: Beijing, 2020; pp 88.
28. 10.1038/s41467-024-53280-810.1038/s41467-024-53280-8 ↗
29. 10.1021/acsami.3c0758210.1021/acsami.3c07582 ↗
30. Hansen, C. M. The Three Dimensional Solubility Parameter and Solvent Diffusion Coeffient; Danish Technical Press: Copenhagen, 1967; p 13–29.
31. 10.1016/j.jconrel.2012.09.00610.1016/j.jconrel.2012.09.006 ↗
32. 10.1038/s41598-021-86484-910.1038/s41598-021-86484-9 ↗
33. 10.3390/molecules2003433710.3390/molecules20034337 ↗
34. 10.1038/s41467-022-35565-y10.1038/s41467-022-35565-y ↗
35. 10.1186/s12950-023-00360-z10.1186/s12950-023-00360-z ↗
36. 10.1016/j.ijbiomac.2019.03.15710.1016/j.ijbiomac.2019.03.157 ↗
37. 10.1186/s40425-018-0371-510.1186/s40425-018-0371-5 ↗
38. 10.1038/s41392-023-01655-610.1038/s41392-023-01655-6 ↗
39. 10.1038/jid.2010.16510.1038/jid.2010.165 ↗
40. 10.1016/j.ijpharm.2017.05.01610.1016/j.ijpharm.2017.05.016 ↗
41. 10.1208/s12248-008-9036-510.1208/s12248-008-9036-5 ↗
42. 10.1016/S0168-3659(99)00166-210.1016/S0168-3659(99)00166-2 ↗
43. 10.3389/fphar.2021.71456610.3389/fphar.2021.714566 ↗
44. 10.1093/nar/gku29310.1093/nar/gku293 ↗
45. 10.1093/nar/gkz102110.1093/nar/gkz1021 ↗
46. 10.3390/pharmaceutics1311179210.3390/pharmaceutics13111792 ↗